Immunomodulating glycopeptide
CA 2363957 A1 · Owner: Imperial Cancer Research Technology Limited · Inventors: Taylor-Papadimitriou, Joyce; Burchell, Joy
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A product which causes super-proliferation of T cells for use in treating or diagnosing a disease, in particular cancer. In one embodiment the product is a glycopeptide with amino acid sequence from the MUC1 tandem repeat. The product may be used to treat cells in vitro or as an adjuvant.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 1, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 1, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 1, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.